Guanhao BiotechLtd Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Yongming Zhang

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	1.3yrs
Promedio de permanencia en la Junta Directiva	4.6yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Yongming Zhang (52 yo)

less than a year

Permanencia

Mr. Yongming Zhang serves as Non-Independent Director and Non-Independent Chairman at Guanhao Biotech Co. Ltd. since April 27, 2018 and also serves as its General Manager since January 12, 2024.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Yongming Zhang	Non-Independent Chairman & GM	less than a year	sin datos	sin datos
Xu Qingrong	Deputy GM & Secretary	1.3yrs	CN¥584.90k	sin datos
Junhui Zhao	Deputy General Manager	1.3yrs	CN¥918.60k	0.0057% CN¥ 194.7k
Feng Zhao	Deputy General Manager	4.7yrs	CN¥1.62m	0.0052% CN¥ 179.2k
Zhen You	Deputy General Manager	3.5yrs	CN¥888.60k	sin datos
Huaixin Hou	Deputy General Manager	1.3yrs	CN¥701.30k	sin datos
Xianggui Lin	Deputy General Manager	1.3yrs	CN¥701.30k	sin datos
Ruofeng Yi	Chief Financial Officer	less than a year	sin datos	sin datos
Guofeng Xu	Chief Technology Officer	no data	CN¥541.70k	sin datos

1.3yrs

Permanencia media

46yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300238 no se considera experimentado ( 0.8 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Yongming Zhang	Non-Independent Chairman & GM	6.5yrs	sin datos	sin datos
Xinzhi Wang	Vice Chairman	4.3yrs	CN¥1.15m	sin datos
Chao Deng	Independent Director	1.3yrs	CN¥53.00k	sin datos
Jianyi Zhao	Non-Employee Supervisor	4.6yrs	sin datos	sin datos
Dan Tian	Chairman of the Supervisory Board	4.6yrs	sin datos	sin datos
Junmei Han	Independent Director	4.6yrs	CN¥100.00k	sin datos
Feng Sun	Non-Independent Director	4.6yrs	sin datos	sin datos
Shuangbing Xian	Supervisor	4.6yrs	sin datos	sin datos

4.6yrs

Permanencia media

53yo

Promedio de edad

Junta con experiencia: La junta directiva de 300238 se considera experimentada (4.1 años de antigüedad promedio).

Guanhao BiotechLtd Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 26, 2024

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 26, 2024

Guanhao Biotech Co.,Ltd. Announces Management Appointments

High number of new and inexperienced directors

High number of new and inexperienced directors

Guanhao Biotech Co.,Ltd., Annual General Meeting, May 18, 2022

Recent updates

Guanhao Biotech Co.,Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Second quarter 2024 earnings released: EPS: CN¥0.027 (vs CN¥0.037 in 2Q 2023)

Guanhao Biotech Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

New minor risk - Share price stability

First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.08 in 1Q 2023)

Guanhao Biotech Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 26, 2024

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥1.16 loss in FY 2022)

Guanhao Biotech Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 06, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.046 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.037 (vs CN¥1.03 loss in 2Q 2022)

Guanhao Biotech Co.,Ltd. to Report First Half, 2023 Results on Aug 23, 2023

Guanhao Biotech Co.,Ltd. Announces Management Appointments

Full year 2022 earnings released: CN¥1.16 loss per share (vs CN¥0.28 profit in FY 2021)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.046 (vs CN¥0.08 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: CN¥1.03 loss per share (vs CN¥0.08 profit in 2Q 2021)

High number of new and inexperienced directors

Guanhao Biotech Co.,Ltd., Annual General Meeting, May 18, 2022

First quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.07 in 1Q 2021)

Third quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.04 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.062 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.07 (vs CN¥0.04 in 1Q 2020)

New 90-day low: CN¥18.95

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 30, 2021

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥1.75 loss in FY 2019)

Guanhao Biotech Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 09, 2021

New 90-day low: CN¥22.15

New 90-day high: CN¥29.88

New 90-day high: CN¥29.30

New 90-day low: CN¥23.15

Third quarter earnings released

Guanhao Biotech Co.,Ltd. to Report Q3, 2020 Results on Oct 27, 2020

Guanhao Biotech Co.,Ltd. (SZSE:300238) intends to acquire 31% stake in ZY Therapeutics Inc. from U.S.TIANYOU CAPITAL CORP for $3.1 million.

New 90-day high - CN¥38.39

Guanhao Biotech Co.,Ltd. to Report First Half, 2020 Results on Jul 21, 2020

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad